- Report
- February 2024
- 90 Pages
Asia Pacific
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 70 Pages
Australia
From €4214EUR$4,750USD£3,670GBP
- Report
- May 2023
- 160 Pages
Global
From €4391EUR$4,949USD£3,823GBP
- Report
- May 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,823GBP
- Report
- March 2026
- 136 Pages
France
From €3548EUR$3,999USD£3,089GBP
- Report
- February 2026
- 149 Pages
Canada
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 134 Pages
Germany
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 133 Pages
Russia
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 131 Pages
China
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 138 Pages
Japan
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 136 Pages
Turkey
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 138 Pages
Brazil
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 128 Pages
Italy
From €3548EUR$3,999USD£3,089GBP
- Report
- July 2024
- 133 Pages
Spain
From €3548EUR$3,999USD£3,089GBP
- Report
- May 2024
- 133 Pages
Global
From €3548EUR$3,999USD£3,089GBP
- Report
- May 2024
- 137 Pages
Global
From €3548EUR$3,999USD£3,089GBP
- Report
- May 2024
- 139 Pages
Global
From €3548EUR$3,999USD£3,089GBP
- Report
- May 2024
- 134 Pages
Global
From €3548EUR$3,999USD£3,089GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more